Changes in Cytokine Production after Measles Virus Vaccination: Predominant Production of IL-4 Suggests Induction of a Th2 Response

Clinical Immunology and Immunopathology

Volumn 67, Issue 2, 1993, Pages 171-177

  Ward, Brian J ^a,b   Griffin, Diane E ^c  

^a Montreal General Hospital ^*

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 4; MEASLES VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LYMPHOCYTE PROLIFERATION; MALE; MEASLES; MEASLES VIRUS; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

ADULT; CYTOKINES; FEMALE; HUMAN; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MEASLES VACCINE; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION;

EID: 0027273501     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1993.1061     Document Type: Article

References (54)

1. Von Pirquet, C., Verhalten der kutanen tuberkulin-reaktion wahrend der Masern. Dtsch. Med. Wochenschr. 34, 1297-1300, 1908.
2. Tamashiro, V. G., Perez, H. H., and Griffin, D. E., Prospective study of the magnitude and duration of changes in tuberculin reactivity during complicated and uncomplicated measles. Pediatr. Infect. Dis. J. 6, 451-454, 1987.
3. Hirsch, R. L., Griffin, D. E., Johnson, R. T., Cooper, S. J., Lindo de Soriano, I., Roedenbeck, S., and Vaisberg, A., Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin. Immunol. Immunopathol. 31, 1-12, 1984.
4. Griffin, D. E., Ward, B. J., Juaregui, E., Johnson, R. T., and Vaisberg, A., Natural killer cell activity during measles Clin. Exp. Immunol. 810, 218-224, 1990.
5. Griffin, D. E., Cooper, S. J., Hirsch, R. L., Johnson, R. T., Lindo de Soriano, I., Roedenbeck, S., and Vaisberg, A., Changes in plasma Ig E levels during complicated and uncomplicated measles virus infections. J. Allergy Clin. Immunol. 76, 206-213, 1985.
6. Miller, D. L., Frequency of complications of measles, 1963. Br. Med. J. 2, 75-78, 1964.
7. Greenberg, B. L., Sack, R. B., Salazar-Lindo, E., Budge, E., Gutierrez, M., Campos, M., Vaisberg, A., Leon-Barua, R., Yi, A., Maurutia, D., Gomez, M., Lindo, I., and Jauregui, E., Measlesassociated diarrhea in hospitalized children in Lima, Peru: Pathogenic agents and impact on growth. J. Infect-Dis. 163, 495-502, 1991.
8. Ward, B. J., Johnson, R. T., Vaisberg, A., Jauregui, E., and Griffin, D. E., Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin. Immunol. Immunopathol. 61, 236-248, 1991.
9. Ward, B. J., Johnson, R. T., Vaisberg, A., Jauregui, E., and Griffin, D. E., Spontaneous proliferation of peripheral mononuclear cells in natural measles virus infection: Identification of dividing cells and correlation with mitogen responsiveness. Clin. Immunol. Immunopathol. 55, 315-326, 1990.
10. Griffin, D. E., Ward, B. J., Jauregui, E., Johnson, R. T., and Vaisberg, A., Immune activation during measles. N. Engl. J. Med. 320, 1667-1672, 1989.
11. Griffin, D. E., Ward, B. J., Jauregui, E., Johnson, R. T., and Vaisberg, A., Immune activation during measles: Interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J. Infect. Dis. 161, 449-453, 1990.
12. Hildreth, E. A., Frederic, M. W., and Randall, P., Alterations in delayed hypersensitivity produced by live attenuated measles virus in man. Trans. Am. Clin. Climatol. Assoc. 75, 37-51, 1963.
13. Fireman, P., Friday, G., and Kumate, J., Effect of measles virus vaccine on immunologic responsiveness. Pediatrics 43, 264-272, 1969.
14. Zweiman, B., Pappagianis, D., Maibach, H., and Hildreth, E. A., Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity. Int. Arch. Allergy Appl. Immunol. 40, 834-841, 1971.
15. Mellman, W. J., and Wetton, R., Depression of the tuberculin reaction by attenuated measles virus vaccine. J. Lab. Clin. Med. 61, 453-458, 1963.
16. Brody, J. A., and Mc Alister, R., Depression of tuberculin sensitivity following measles vaccination. Am. Rev. Respir. Dis. 90, 607-611, 1964.
17. Starr, S., and Berkovich, S., Effects of measles, gamma-globulinmodified measles and vaccine measles on the tuberculin test. N. Engl. J. Med. 270, 386-391, 1964.
18. Hirsch, R. L., Mokhtarian, F., Griffin, D. E., Brooks, B. R., Hess, J., and Johnson, R. T., Measles virus vaccination of measles seropositive individuals suppress lymphocyte proliferation and chemo tactic factor production. Clin. Immunol. Immunopathol. 21, 341-350, 1981.
19. Munyer, T. P., Mangi, R. J., Dolan, T., and Kantor, F. S., Depressed lymphocyte function after measles-mumps-rubella vaccination. J. Infect. Dis. 132, 75-78, 1975.
20. Fuchs, D., Hausen, A., Reibnegger, G., Werner, E. R., Dierich, M. P., and Wachter, H., Neopterin as a marker for activated cell mediated immunity: Application in HIV infection. Immunol. Today 150-155, 1988.
21. Garenne, M., Leroy, O., Beau, J-P., and Sene, I., Child mortality after high-titre measles vaccines: Prospective study in Senegal. Lancet 338, 903-907, 1991.
22. Mosmann, T. R., Cytokine secretion patterns and crossregulation of T cell subsets. Immunol. Res. 10, 183-188, 1991.
23. Ehlers, S., and Smith, K. A., Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J. Exp. Med. 173, 25-36, 1991.
24. + T cells producing IL-2 or IL-4. J. Immunol. 148, 1031-1036, 1992.
25. + T cells can be primed in vitro to produce IL-4. J. Immunol. 148, 1652-1656, 1992.
26. + T cell clones. J. Immunol. 141, 849-855, 1988.
27. Weaver, C. T., Hawrylowicz, C. M., and Unanue, E. R., T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc. Natl. Acad. Sci. USA 85, 8181-8185, 1988.
28. Swain, S. L., Mc Kenzie, D. T., Weinberg, A. D., and Hancock, W., Characterization of T helper 1 and 2 cell subsets in normalmice: Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J. Immunol. 141, 3445-3455, 1988.
29. Jabara, H. H., Ahern, D. J., Vercelli, D., and Geha, R. S., Hydrocortisone and IL-4 induce Ig E isotype switching in human B cells. J. Immunol. 147, 1557-1560, 1991.
30. Mitchell, L. C., Davis, L. S., and Lipsky, P. E., Promotion of human T lymphocyte proliferation by IL-4. J. Immunol. 142, 1548-1557, 1989.
31. Martinez, O. M., Gibbons, R. S., Garovoy, M. R., and Aronson, F. R., IL-4 inhibits IL-2 receptor expression and IL-2 dependent proliferation of human T cells. J. Immunol. 144, 2211-2215, 1990.
32. te Velde, A. A., Klomp, J. P. G., Yard, B. A., de Vries, J. E., and Figdor, C. G., Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J. Immunol. 140, 1548-1554, 1988.
33. Essner, R., Rhoades, K., Mc Bride, W. H., Morton, D. L., and Economou, J. S., IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J. Immunol. 142, 3857-3861, 1989
34. Donnelly, R. P., Fenton, M. J., Kaufman, J. D., and Gerrard, T. L., IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4, J. Immunol. 146, 3431-3436, 1991.
35. Hart, P. H., Vitti, G. F., Burgess, D. R., Whitty, G. A., and Piccoli, D. S., Potential antiinflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc. Natl. Acad. Sci. USA 86, 3803-3807, 1989.
36. Bello-Femandez, C., Oblakowski, P., Meager, A., Duncombe, A. S., Rill, D. M., Hoffbrand, A. V., and Brenner, M. K., IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFNgamma. Immunology 72, 161-166, 1991.
37. Donnelly, R. P., Fenton, M.J., Finbloom, D. S., and Gerrard, T. L., Differential regulation of IL-1 production in human monocytes by IFN-gamma and IL-4. J. Immunol. 145, 569-575, 1990.
38. Gobi, A. E., and Aim, G. V., Interleukin-4 down-regulates Sendai virus-induced production of interferon-alpha and -beta in human peripheral blood monocytes in vitro. Scand. J. Immunol. 35, 167-175, 1992.
39. te Velde, A. A., Huijbens, R. J. F., de Vries, J. E., and Figdor, C. G., IL-4 decreases Fc-gamma-R membrane expression and Fcgamma-R-mediated cytotoxic activity of human monocytes. J. Immunol. 144, 3046-3051, 1990.
40. Lehn, M., Weiser, W. Y., Engelhorn, S., Gillis, S., and Remold, H. G., IL-4 inhibits H202 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma. J. Immunol. 143, 3020-3024, 1989.
41. Wong, H. L., Welch, G. R., Brandes, M. E., and Wahl, S. M., IL-4 antagonizes induction of Fc-gamma-RIII (CD 16) expression by transforming growth factor-beta on human monocytes. J. Immunol. 147, 1843-1848, 1991.
42. Abramson, S. L., and Gallin, J. I., IL-4 inhibits superoxide production by human mononuclear phagocytes. J. Immunol. 144, 625-630, 1990.
43. Ho, J. L., He, S. H., Rios, M. J. C., and Wick, E. A., Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity. J. Infect. Dis. 165, 344-351, 1992.
44. Wong, H. L., Lotze, M. T., Wahl, L. M., and Wahl, S. M., Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. J. Immunol. 148, 2118-2125, 1992.
45. Kovacs, E. J., Radzioch, D., Young, H. A., and Varesio, L., Differential inhibition of IL-1 and TNF-alpha m RNA expression by agents which block second messenger pathways in murine macrophages. J. Immunol. 141, 3101-3105, 1988.
46. Châtelain, R., Varkila, K., and Coffman, R. L., IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148, 1182-1187, 1992.
47. Gautam, S. C., Chikkala, N. F., and Hamilton, T. A., Antiinflammatory action of IL-4: Negative regulation of contact sensitivity to trinitrochlorobenzene. J. Immunol. 148, 1411-1415, 1992.
48. Taga, K., and Tosato, G., IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148, 1143-1148, 1992.
49. Malefyt, R. D. W., Haanen, J., Spits, H., Roncarolo, M.G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., and de Vries, J. E., Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915-924, 1991.
50. Romagnani, S., Human THl and TH2 subsets: Doubt no more. Immunol. Today 12, 256-257, 1991.
51. Yamamura, M., Uyemura, K., Deans, R. J., Weinberg, K., Rea, T. H., Bloom, B. R., and Modlin, R. L., Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254, 277-279, 1991.
52. Salgame, P., Abrams, J. S., Clayberger, C., Goldstein, H., Convit, J., Molin, R. L., and Bloom, B. R., Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254, 279-282, 1991.
53. Scott, P., and Kaufmann, S. H. E., The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today 12(10), 346-348, 1991.
54. + subset regulation in viral infection: Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J. Immunol. 148, 182-188, 1992.